Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 20.756% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
(a) N#CCN1CCC(c2cc(-c3ccco3)n[nH]2)CC1
(b) O=c1[nH]c(=S)n(Cc2ccc(F)cc2)c(O)c1C=NCc1ccc2c(c1)OCO2
Answer: b. O=c1[nH]c(=S)n(Cc2ccc(F)cc2)c(O)c1C=NCc1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
O=c1[nH]c(=S)n(Cc2ccc(F)cc2)c(O)c1C=NCc1ccc2c(c1)OCO2
O=c1[nH]c(=S)n(Cc2ccc(F)cc2)c(O)c1C=NCc1ccc2c(c1)OCO2
5-(1,3-benzodioxol-5-ylmethyliminomethyl)-1-[(4-fluorophenyl)methyl]-6-hydroxy-2-sulfanylidenepyrimidin-4-one